<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737590</url>
  </required_header>
  <id_info>
    <org_study_id>123456</org_study_id>
    <nct_id>NCT04737590</nct_id>
  </id_info>
  <brief_title>Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts</brief_title>
  <official_title>A Randomized Clinical Trial Comparing Curettage With Allogenic Bone Grafting and Curettage With Bioactive Glass Filling in Children With Bone Cysts CYSTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bonalive Biomaterials Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Finnish Paediatric Orthopedic Study Group will perform a prospective, randomized,&#xD;
      multicenter, clinical trial comparing two bone substitutes (allograft and bioactive glass,&#xD;
      BonAlive®) in treating bone cysts in children (18 years or younger). The trial is carried out&#xD;
      in five University Hospitals (Turku, Helsinki, Tampere, Oulu, Kuopio) in Finland.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients will be randomized into each group. In all University Hospitals the treatment&#xD;
      protocol will be same. Randomization will be performed using a sealed envelope technique.&#xD;
&#xD;
      Before surgery all patients will be examined clinically. After conventional radiographs all&#xD;
      patients will be examined with magnetic resonance imaging showing cyst's size, anatomy,&#xD;
      location and adjacent structures.&#xD;
&#xD;
      If the aneurysmal bone cyst is large or in difficult location, embolization by the&#xD;
      radiologist can be used preoperatively.&#xD;
&#xD;
      Surgical technique:&#xD;
&#xD;
      Surgery will be done by experienced paediatric orthopaedic surgeons. Normal orthopaedic&#xD;
      exposures will be used. The cyst is opened so that square window is done to the cortex. A&#xD;
      sample to the pathologist is collected, also intraoperative frozen section is used to confirm&#xD;
      the diagnosis. A mechanical curettage with use of a curette and a high speed burr is used to&#xD;
      inspect the whole cavity. The tumour is resected as thoroughly as possible. After curettage&#xD;
      5% phenol is inserted to the cavity and it is neutralized with saline. Cyst volume is&#xD;
      evaluated using saline (ml). Then the cyst is filled with morsellized femoral head allograft&#xD;
      or bioactive glass (BG-S53P4) according to randomization. The biggest granule size 2-3,15mm&#xD;
      is used for femur, tibia, pelvis and humerus. If the cyst volume is below 10ml in these&#xD;
      places then smaller granule size (1-2mm) is chosen. If the cyst is in hand region then the&#xD;
      granule size is 0,5-0,8mm. At the end of the operation the window's roof is inserted back.&#xD;
      All the time X-ray is used to ensure that the whole cyst is treated properly. Osteosynthesis&#xD;
      will be performed whenever it is necessary to prevent a pathological fracture.&#xD;
&#xD;
      After surgery the diagnosis will be confirmed histopathologically.&#xD;
&#xD;
      All patients will receive standard anesthesia.&#xD;
&#xD;
      Postoperatively an X-ray will be taken. Radiographic controls after surgery will be held at 1&#xD;
      Mo, 3 Mo, 6Mo, 12Mo and 24Mo. Three months control and two years control will be accompanied&#xD;
      with MRI.&#xD;
&#xD;
      If the cyst is found after a pathologic fracture, the fracture is healed first with the cast&#xD;
      +/- traction and MRI will be taken before surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2012</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>Cyst's recurrence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence size</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>The size of cyst recurrence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operation time</measure>
    <time_frame>during the surgery</time_frame>
    <description>Time from the cut to the closure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>during the surgery</time_frame>
    <description>Operation's blood loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>during the surgery</time_frame>
    <description>Complications at the operation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>Complications during follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>immediately after the surgery</time_frame>
    <description>Number of days spent at the hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cyst-healing grade (Enneking's grading system)</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>Enneking's grading system (scale 1-3, 1=latent, 2=active, 3=aggressive)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Function (Musculoskeletal society tumor score)</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>Musculoskeletal society tumor score (scale 0-5, 5=best outcome, 0=worst outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fracture after operation</measure>
    <time_frame>through study completion, average 2 years</time_frame>
    <description>Fracture after operation at the filled area in radiograph (yes / no)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bone Cysts</condition>
  <arm_group>
    <arm_group_label>Bioactive glass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 bone cysts (in 20 patients) are filled with bioactive glass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allogenic bone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 bone cysts (in 20 patients) are filled with allogenic bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioactive glass</intervention_name>
    <description>Comparison of bioactive glass to allogenic bone in pediatric bone cysts</description>
    <arm_group_label>Allogenic bone</arm_group_label>
    <arm_group_label>Bioactive glass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Suspected aneurysmatic bone cyst in all areas, not spinal.&#xD;
&#xD;
          2. Other large simple bone cyst in load bearing areas&#xD;
&#xD;
          3. Simple or aneurysmal bone cyst and a pathological fracture in non load-bearing areas&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Malignancy&#xD;
&#xD;
          2. Bone marrow disease&#xD;
&#xD;
          3. Other than aneurysmatic or simple bone cyst&#xD;
&#xD;
          4. A secondary aneurysmal bone cyst (ABC associated with another underlying lesion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilkka Helenius, Prof</last_name>
    <role>Study Director</role>
    <affiliation>University of Helsinki</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johanna Syvänen, PhD</last_name>
    <phone>+358 2 313 0000</phone>
    <email>johanna.syvanen@tyks.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ilkka Helenius, Prof</last_name>
    <email>ilkka.helenius@tyks.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yrjänä Nietosvaara, PhD</last_name>
      <email>yrjana.nietosvaara@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenni Jalkanen, Phd</last_name>
      <email>jenni.jalkanen@kys.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juha-Jaakko Sinikumpu, Prof</last_name>
      <email>juha-jaakko.sinikumpu@ppshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Salonen, PhD</last_name>
      <email>anne.salonen@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Syvänen, PhD</last_name>
      <phone>+358 2 313 0000</phone>
      <email>johanna.syvanen@tyks.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysts</mesh_term>
    <mesh_term>Bone Cysts</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

